Ong, H.W.; Yang, X.; Smith, J.L.; Taft-Benz, S.; Howell, S.; Dickmander, R.J.; Havener, T.M.; Sanders, M.K.; Brown, J.W.; Couñago, R.M.;
et al. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules 2024, 29, 4158.
https://doi.org/10.3390/molecules29174158
AMA Style
Ong HW, Yang X, Smith JL, Taft-Benz S, Howell S, Dickmander RJ, Havener TM, Sanders MK, Brown JW, Couñago RM,
et al. Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules. 2024; 29(17):4158.
https://doi.org/10.3390/molecules29174158
Chicago/Turabian Style
Ong, Han Wee, Xuan Yang, Jeffery L. Smith, Sharon Taft-Benz, Stefanie Howell, Rebekah J. Dickmander, Tammy M. Havener, Marcia K. Sanders, Jason W. Brown, Rafael M. Couñago,
and et al. 2024. "Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2" Molecules 29, no. 17: 4158.
https://doi.org/10.3390/molecules29174158
APA Style
Ong, H. W., Yang, X., Smith, J. L., Taft-Benz, S., Howell, S., Dickmander, R. J., Havener, T. M., Sanders, M. K., Brown, J. W., Couñago, R. M., Chang, E., Krämer, A., Moorman, N. J., Heise, M., Axtman, A. D., Drewry, D. H., & Willson, T. M.
(2024). Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules, 29(17), 4158.
https://doi.org/10.3390/molecules29174158
